http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2013346447-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_63548afa53c546869ef4735ab1aba501
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0004
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
filingDate 2013-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6378cb8e0ab1757f63fa4af5bbd524c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0783fdbc5b51c521ca81d5dad201607
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_918aa1a2b792751d06e5b45b91a45676
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8c0ce340dce5561b47dae5270ea4507
publicationDate 2015-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2013346447-A1
titleOfInvention Kit for diagnosing gluten sensitivity
abstract The present invention relates to a method for determining gluten sensitivity which uses a kit comprising: a kit identification code, at least one oral formulation of gluten and at least one oral formulation of placebo, each identified by a code, for random double-blind administration. The method provides for at least one step of taking said at least one oral formulation of gluten and said at least one oral formulation of placebo according to a double-blind protocol; and at least one step of collecting data relating to the heath status of said subject.
priorityDate 2012-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4550
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24836924
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260423
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4550

Total number of triples: 19.